Previous Close | 23.91 |
Open | 23.40 |
Bid | 23.25 x 300 |
Ask | 23.33 x 600 |
Day's Range | 23.07 - 23.43 |
52 Week Range | 18.45 - 37.71 |
Volume | |
Avg. Volume | 701,922 |
Market Cap | 974.703M |
Beta (5Y Monthly) | 1.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.08 |
Earnings Date | May 02, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 35.00 |
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SEATTLE, April 25, 2024--As the number one most frequently claimed condition among Trupanion pet parents, allergies in pets are a topic of increasing priority for pet parents. With over 20 years of pet health data, Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has conducted a deep dive into its veterinary invoice data, revealing trends and insights as well as offering some practical tips for pet parents.
SEATTLE, April 22, 2024--Trupanion (Nasdaq: TRUP), the leading provider of pet medical insurance, is proud to announce the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions covering topics relevant to everyday pet health, offering data-driven insights and practical advice to pet parents.